Diabetes Glucose Management


Activity Description

CME Release Date: April 24, 2011
CME Expiration Date: April 24, 2012

Statement of Need

Because the majority of people with diabetes are cared for by their primary care providers, PCPs need a comprehensive review and update on diabetes management to provide optimal care. Advances in Diabetes, an annual CME course, initiated more than century ago by Elliott P. Joslin, MD, in conjunction with Harvard Medical School, is the longest-running continuously offered academic course in diabetes in the United States and, likely, the world. The course has evolved with diabetes practice and research as well as the changing continuing education needs of the medical profession.

This Internet enduring material was developed from the following presentations by the faculty on November 11, 2010 at the Advances in Diabetes 2010 course in Boston, MA.

  1. Should Treatment Goals for Type 2 Diabetes Be Changed?
    Edward Horton, MD
  2. Type 2 Diabetes and Cardiometabolic Syndrome
    Glenn Matfin, MSc (Oxford), MB ChB, FACE, FACP, FRCP
  3. The Burgeoning Epidemic of Obesity in the USA
    Osama Hamdy, MD, PhD, FACE


Target Audience

This certified activity was developed for primary care providers with a practice population that includes significant numbers of people with diabetes.

Learning Objectives

After participating in this educational activity, healthcare professionals should be able to:
  1. Use appropriate professional judgment along with guidelines in setting A1C goals for their patients.
  2. Employ a cardiovascular risk stratification program to identify patients at cardiovascular risk.
  3. Treat cardiovascular risk factors such as lipids and hypertension according to ADA guidelines.
  4. Explain the benefits of weight reduction on diabetes control in type 2 diabetes.

Faculty and Disclosures

Osama Hamdy, MD, PhD, FACE
Harvard Medical School
Medical Director
Obesity Clinical Program
Joslin Diabetes Center

Disclosure: Dr. Osama Hamdy is on the speakers bureau for Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Novo Nordisk Inc., and Takeda Pharmaceuticals North America, Inc.

Edward S. Horton, MD
Professor of Medicine
Harvard Medical School
Senior Investigator
Joslin Diabetes Center

Disclosure: Dr. Edward S. Horton is on the advisory board for Abbott Laboratories, Amylin Pharmaceuticals, Inc., Bristol-Meyers Squibb Company, Daiichi Sankyo, Inc., F. Hoffman-La Roche Inc., GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., and sanofi-aventis U.S. LLC; receives grant/research support from Amylin Pharmaceuticals, Inc.; is on the steering committee for Medtronic, Inc.; on the speakers bureau for Merck & Co., Inc.; and on the data monitoring board for Takeda Pharmaceuticals North America, Inc.

Glenn Matfin, MSc (Oxford), MB ChB, FACE, FACP, FRCP
Harvard Medical School
Senior Physician
Joslin Diabetes Center

Disclosure: Dr. Glenn Matfin has no relevant financial relationships.

Planning Committee:

Martin J. Abrahamson, MD
Associate Professor of Medicine
Harvard Medical School
Medical Director and Senior Vice President
Joslin Diabetes Center
Boston, MA

Dr. Martin J. Abrahamson is on the advisory board for Halozyme Therapeutics, Merck & Co., Inc., Novo Nordisk Inc., and sanofi-aventis U.S. LLC, and receives grant/research support from Pfizer Inc.

Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director
Professional Education
Joslin Diabetes Center


Dr. Richard S. Beaser, Medical Executive Director, Professional Education, Joslin Diabetes Center, is a consultant for CeQur Ltd.

Accreditation and Designation of Credit

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The Harvard Medical School designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants not eligible for CME credit will receive a certificate of completion.

Computer Requirements

To participate in this activity, your computer will need the following hardware and software:

PC Users:
Macintosh Users System OS X:
Credit Instructions
  1. Read the learning objectives, accreditation information, and faculty disclosures at the beginning of the activity.
  2. Click on the link below to register for the Webcast and view the online video and slides
  3. Complete the online posttest and evaluation.
  4. Physicians who receive a grade of 60% or better on the posttest and who complete the evaluation will receive a CME certificate as a PDF sent to their email address.
  5. All other participants who receive a grade of 60% or better on the posttest and who complete the evaluation will receive a certificate of completion as a PDF sent to their email address.

Questions About This Activity

For questions regarding this activity, including technical support, please contact cme@joslin.harvard.edu.

To read the policy on privacy and confidentiality that relates to the CME activity, click here.